An interventional study of Primary PCI in ST Elevation Myocardial Infarction, sponsored by Hospital Universitario La Fe. Recruiting at 23 sites in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by Hospital Universitario La Fe · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 41 studies in ST Elevation Myocardial Infarction with a site in Spain — 4 open to participants now, 10 under way, 1 of them phase 3. ST Elevation Myocardial Infarction · Spain.
Among the 41 studies in ST Elevation Myocardial Infarction with a site in Spain, this one is the 8th largest by planned enrollment of the 27 interventional ones that give a count, is the only one that started in 2024, is one of 16 with no phase, and was the 34th registered.
855 studies on the registry are indexed under ST Elevation Myocardial Infarction; 201 are open to participants now.
Browse ST Elevation Myocardial Infarction studies →4 of the 41 studies in ST Elevation Myocardial Infarction with a site in Spain are open now. Recruiting first, the newest first:
Hospital General Universitario Santa Lucia · Sites in Spain
Ages 18+
Fundación Interhospitalaria para la Investigación Cardiovascular FIC · Sites in Spain
Ages 18+
Hospital Arnau de Vilanova · Sites in Spain
Ages 18+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 124 ST Elevation Myocardial Infarction studies recruiting now, 78 (63%) set no upper age limit and 20 (16%) stop at 75 or younger; 10 take children under 18; 9 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
41 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 1 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,272 is above the median of 194 across 531 interventional studies indexed under ST Elevation Myocardial Infarction.
Median enrollment 450 across the 27 interventional studies, 495 across the 14 observational. Of the 24 that completed or were terminated, 5 (21%) have results posted.
This tab as a report to print or save as PDF → With an account.
14 of 41 have an industry lead sponsor. The 10 most frequent:
Hospital Universitario La Fe is the lead sponsor of 39 studies on the registry; 5 are open to participants now.
Hospital Universitario La Fe has 1 study filed under ST Elevation Myocardial Infarction — fewer than ten, so there is no comparison to draw.
4 of the studies in ST Elevation Myocardial Infarction with a site in Spain that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07102628Phase 3Novartis PharmaceuticalsEvaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes | 2027-01-16 |
| NCT07780942Hospital General Universitario Santa LuciaSMARTwatch for the Diagnosis of ST-segment Elevation Myocardial Infarction in Patients With Chest Pain | 2027-02 |
| NCT07000266Fundacio Privada Mon Clinic BarcelonaThe RECOVERY Study: Using Supersaturated Oxygen Therapy To Treat Small Vessel Blockages After a Heart Attack | 2027-05-16 |
| NCT07444957Fundación Interhospitalaria para la Investigación Cardiovascular FICSafety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease | 2027-07-05 |
Add all 4 to your calendar (.ics) → With an account.
Among the 41 studies in ST Elevation Myocardial Infarction with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The objective is to compare a reduced stent strategy based on drug-coated balloon (DCB) percutaneous coronary intervention (PCI) with conventional drug-eluting stent (DES) coronary revascularization in patients presenting with ST-segment myocardial infarction (STEMI).
Randomization will be performed after successful culprit-lesion guidewire crossing and flow restoration. Random allocation in a 1:1 fashion to one of the following strategies:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
- Patients presenting with STEMI and indication to undergo pPCI.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
LVEF (left ventricular ejection fraction)
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Reduced stent PCI strategy: Culprit lesion revascularization with DCB will be performed after coronary predilation if residual stenosis ≤30%, lack of dissections \>type B and TIMI 3 flow. If the aforementioned culprit-lesion characteristics are not achieved after DCB-PCI, a DES will be implanted.
Device: Primary PCI
Control group
Coronary percutaneous revascularization
Target lesion failure (TLF)
Target-vessel myocardial infarction or ischemia-driven target-lesion revascularization
Time frame: 12 months
Incidence of all-cause death
Physicians Assessment
Time frame: 10 years
Incidence of myocardial infarction
Physicians Assessment
Time frame: 10 years
Incidence of cardiovascular death
Physicians Assessment
Time frame: 10 years
Incidence of target lesion revascularization
Physicians Assessment
Time frame: 10 years
Incidence of stent thrombosis
Physicians Assessment
Time frame: 10 years
Incidence of acute vessel closure
Physicians Assessment
Time frame: 10 years
Incidence of stroke
Physicians Assessment
Time frame: 10 years
Incidence of acute kidney injury
Physicians Assessment
Time frame: 10 years
Incidence of bleeding
Physicians Assessment
Time frame: 10 years
Plan to share: No
Started Mar 2024 (actual). Primary completion is estimated for Mar 2028, 48 months after the start.
Of 135 non-industry interventional studies with no phase under ST Elevation Myocardial Infarction, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 70. This study's planned 48 months is above that.
Counting every sponsor, half of 145 studies reached it within 40 months; a quarter within 19 and three quarters within 64.
Primary completion moved once since we started tracking on Sep 25, 2026: Sep 2026 → Mar 2028, on Nov 20, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
ST Elevation Myocardial Infarction →
Hospital Universitario La Fe